Clinical Trial Update: Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating somatropin with leuprorelin versus somatropin alone in pubertal children with idiopathic short stature has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Leuprorelin (leuprorelin)
• Somatropin (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Idiopathic Short Stature (ISS) | Phase 3 | Status: COMPLETED | Results posted: 2016-10-18